MEP27608A - Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same - Google Patents

Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same

Info

Publication number: MEP27608A
Authority: ME; Montenegro
Prior art keywords: medicament; treatment; well; diseases; production
Prior art date: 2002-06-04

Application number

MEP-276/08A

Other languages

Bosnian (bs)

English (en)

Inventor

Hans-Jochen Lang

Uwe Heinelt

Armin Hofmeister

Klaus Wirth

Michael Gekle

Markus Bleich

Original Assignee

Sanofi Aventis Deutschland

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-04

Filing date

2003-05-26

Publication date

2010-06-10

2003-05-26 Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland

2010-06-10 Publication of MEP27608A publication Critical patent/MEP27608A/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4168—1,3-Diazoles having a nitrogen attached in position 2, e.g. clonidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Diabetes (AREA)
Heart & Thoracic Surgery (AREA)
Tropical Medicine & Parasitology (AREA)
Urology & Nephrology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Toxicology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Plural Heterocyclic Compounds (AREA)

MEP-276/08A 2002-06-04 2003-05-26 Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same MEP27608A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10224892A DE10224892A1 (de)	2002-06-04	2002-06-04	Substituierte Thiophene, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
PCT/EP2003/005465 WO2003101984A1 (de)	2002-06-04	2003-05-26	Substituierte thiophene, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament

Publications (1)

Publication Number	Publication Date
MEP27608A true MEP27608A (en)	2010-06-10

Family

ID=29557542

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MEP-276/08A MEP27608A (en)	2002-06-04	2003-05-26	Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same

Country Status (32)

Country	Link
EP (1)	EP1513834B1 (xx)
JP (1)	JP4511924B2 (xx)
KR (1)	KR101087966B1 (xx)
CN (1)	CN1324024C (xx)
AR (1)	AR040239A1 (xx)
AT (1)	ATE320425T1 (xx)
AU (1)	AU2003273553B2 (xx)
BR (1)	BR0311548A (xx)
CA (1)	CA2488242C (xx)
CR (1)	CR7577A (xx)
DE (2)	DE10224892A1 (xx)
DK (1)	DK1513834T3 (xx)
EC (1)	ECSP045471A (xx)
ES (1)	ES2258722T3 (xx)
HR (1)	HRP20041153A2 (xx)
IL (1)	IL165519A (xx)
MA (1)	MA27204A1 (xx)
ME (1)	MEP27608A (xx)
MX (1)	MXPA04011986A (xx)
MY (1)	MY129832A (xx)
NO (1)	NO329351B1 (xx)
OA (1)	OA12827A (xx)
PE (1)	PE20040534A1 (xx)
PL (1)	PL372589A1 (xx)
PT (1)	PT1513834E (xx)
RS (1)	RS51141B (xx)
RU (1)	RU2315766C2 (xx)
TN (1)	TNSN04240A1 (xx)
TW (1)	TWI283675B (xx)
UA (1)	UA77551C2 (xx)
WO (1)	WO2003101984A1 (xx)
ZA (1)	ZA200409095B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040242560A1 (en)	2003-05-22	2004-12-02	Aventis Pharma Deutschland Gmbh	Process for synthesizing heterocyclic compounds
DE10323701A1 (de)	2003-05-22	2004-12-23	Aventis Pharma Deutschland Gmbh	Verfahren zur Synthese heterocyclischer Verbindungen
JP4384635B2 (ja)	2003-06-30	2009-12-16	住友化学株式会社	不斉尿素化合物およびこれを触媒として用いる不斉共役付加反応による不斉化合物の製造方法
WO2008051533A2 (en) *	2006-10-25	2008-05-02	Takeda Pharmaceutical Company Limited	Benzimidazole compounds
CA2735842A1 (en)	2008-09-02	2010-03-11	Sanofi-Aventis	Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof
RU2373929C1 (ru) *	2008-11-11	2009-11-27	Государственное образовательное учреждение высшего профессионального образования "БАШКИРСКИЙ ГОСУДАРСТВЕННЫЙ МЕДИЦИНСКИЙ УНИВЕРСИТЕТ Федерального Агентства по здравоохранению и социальному развитию" (ГОУ ВПО БГМУ РОСЗДРАВА)	Корректор системы гемостаза, проявляющий ингибирующее действие на адгезивно-агрегационную функцию тромбоцитов для профилактики патологического тромбообразования
CN102712601A (zh) *	2009-11-12	2012-10-03	赛尔维他股份公司	化合物、其制备方法、药物组合物、化合物的用途、用于调节或调控丝氨酸/苏氨酸激酶的方法以及丝氨酸/苏氨酸激酶调节剂
RU2518740C1 (ru) *	2013-03-22	2014-06-10	Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ"	СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ДИГИДРОХЛОРИД 2-(3,4-МЕТИЛЕНДИОКСИФЕНИЛ)-9-МОРФОЛИНОЭТИЛИМИДАЗО[1,2-a]БЕНЗИМИДАЗОЛА
BR112017000691B1 (pt)	2014-07-25	2023-02-14	Taisho Pharmaceutical Co., Ltd	Feniltetra-hidroisoquinolina substituído com heteroari-la, seu uso, medicamento, inibidores de nhe3, de absorção de sódio e de absorção de fósforo, promotor de secre-ção de água intestinal e fármaco profilático ou terapêu-tico para constipação
KR102840252B1 (ko) *	2023-04-27	2025-07-30	한국화학연구원	시아노벤즈이미다졸 유도체, 약제학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 약제학적 조성물
CN120112529A (zh) *	2023-09-28	2025-06-06	四川大学华西医院	一种含吡啶的化合物及其制备方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE754820R (fr) *	1969-08-13	1971-02-15	Schering Ag	Nouveaux derives de pyrimidine, leurs procedes de preparation et leurs
BR6915362D0 (pt) *	1969-08-16	1973-01-04	Hoechst Ag	Processo para a preparacao de 2(tienil-3-amino)1,3-diazacicloalquenos
DE2830279A1 (de) *	1978-07-10	1980-01-31	Boehringer Sohn Ingelheim	2-eckige klammer auf n-(2'-chlor-4'- methyl-thienyl-3')-n-(cyclopropylmethyl)- amino eckige klammer zu-imidazolin-(2), dessen saeureadditionssalze, dieses enthaltende arzneimittel und verfahren zu seiner herstellung
US5395847A (en) *	1993-12-02	1995-03-07	Smithkline Beecham Corporation	Imidazolyl-alkenoic acids
EP1100506A4 (en) *	1998-07-29	2002-06-26	Merck & Co Inc	INTEGRIN RECEPTOR ANTAGONISTS
DE19921883A1 (de) *	1999-05-12	2000-11-16	Bayer Ag	Substituierte Thienocycloalk(en)ylamino-1,3,5-triazine
DE19960204A1 (de) *	1999-12-14	2001-06-28	Aventis Pharma Gmbh	Substituierte Norlbornylamino-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
JP4628678B2 (ja) *	2002-03-29	2011-02-09	ノバルティスバクシンズアンドダイアグノスティックス，インコーポレーテッド	置換ベンズアゾールおよびＲａｆキナーゼ阻害剤としてのそれらの使用

2002
- 2002-06-04 DE DE10224892A patent/DE10224892A1/de not_active Withdrawn
2003
- 2003-05-26 JP JP2004509675A patent/JP4511924B2/ja not_active Expired - Fee Related
- 2003-05-26 WO PCT/EP2003/005465 patent/WO2003101984A1/de not_active Ceased
- 2003-05-26 MX MXPA04011986A patent/MXPA04011986A/es active IP Right Grant
- 2003-05-26 DE DE50302673T patent/DE50302673D1/de not_active Expired - Lifetime
- 2003-05-26 UA UA20041211000A patent/UA77551C2/uk unknown
- 2003-05-26 PL PL03372589A patent/PL372589A1/xx not_active Application Discontinuation
- 2003-05-26 OA OA1200400321A patent/OA12827A/en unknown
- 2003-05-26 ES ES03740148T patent/ES2258722T3/es not_active Expired - Lifetime
- 2003-05-26 CN CNB038128462A patent/CN1324024C/zh not_active Expired - Fee Related
- 2003-05-26 EP EP03740148A patent/EP1513834B1/de not_active Expired - Lifetime
- 2003-05-26 CA CA2488242A patent/CA2488242C/en not_active Expired - Fee Related
- 2003-05-26 PT PT03740148T patent/PT1513834E/pt unknown
- 2003-05-26 DK DK03740148T patent/DK1513834T3/da active
- 2003-05-26 HR HR20041153A patent/HRP20041153A2/xx not_active Application Discontinuation
- 2003-05-26 ME MEP-276/08A patent/MEP27608A/xx unknown
- 2003-05-26 BR BR0311548-8A patent/BR0311548A/pt not_active IP Right Cessation
- 2003-05-26 AT AT03740148T patent/ATE320425T1/de active
- 2003-05-26 AU AU2003273553A patent/AU2003273553B2/en not_active Ceased
- 2003-05-26 RS YUP-1038/04A patent/RS51141B/sr unknown
- 2003-05-26 KR KR1020047019725A patent/KR101087966B1/ko not_active Expired - Fee Related
- 2003-05-26 RU RU2004138812/04A patent/RU2315766C2/ru not_active IP Right Cessation
- 2003-05-30 PE PE2003000531A patent/PE20040534A1/es not_active Application Discontinuation
- 2003-06-02 TW TW092114860A patent/TWI283675B/zh not_active IP Right Cessation
- 2003-06-02 AR ARP030101958A patent/AR040239A1/es active IP Right Grant
- 2003-06-03 MY MYPI20032052A patent/MY129832A/en unknown
2004
- 2004-11-10 ZA ZA200409095A patent/ZA200409095B/xx unknown
- 2004-11-16 MA MA27952A patent/MA27204A1/fr unknown
- 2004-11-19 CR CR7577A patent/CR7577A/es unknown
- 2004-12-02 EC EC2004005471A patent/ECSP045471A/es unknown
- 2004-12-02 IL IL165519A patent/IL165519A/en not_active IP Right Cessation
- 2004-12-03 TN TNP2004000240A patent/TNSN04240A1/en unknown
- 2004-12-16 NO NO20045504A patent/NO329351B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
MY129832A (en)	2007-05-31
JP2005533038A (ja)	2005-11-04
RS103804A (sr)	2006-12-15
TNSN04240A1 (en)	2007-03-12
TW200406409A (en)	2004-05-01
HRP20041153A2 (en)	2005-06-30
AU2003273553B2 (en)	2008-12-04
MXPA04011986A (es)	2005-03-07
NO20045504L (no)	2005-01-25
WO2003101984A1 (de)	2003-12-11
AU2003273553A1 (en)	2003-12-19
RU2004138812A (ru)	2005-07-20
OA12827A (en)	2006-07-11
DE50302673D1 (de)	2006-05-11
DK1513834T3 (da)	2006-07-17
ZA200409095B (en)	2005-05-10
HK1076460A1 (en)	2006-01-20
MA27204A1 (fr)	2005-01-03
RU2315766C2 (ru)	2008-01-27
PT1513834E (pt)	2006-06-30
TWI283675B (en)	2007-07-11
RS51141B (sr)	2010-10-31
CR7577A (es)	2005-06-16
CA2488242C (en)	2011-08-02
BR0311548A (pt)	2005-04-12
IL165519A0 (en)	2006-01-15
DE10224892A1 (de)	2003-12-18
UA77551C2 (en)	2006-12-15
EP1513834A1 (de)	2005-03-16
IL165519A (en)	2010-05-31
JP4511924B2 (ja)	2010-07-28
EP1513834B1 (de)	2006-03-15
KR101087966B1 (ko)	2011-12-01
PE20040534A1 (es)	2004-10-25
ATE320425T1 (de)	2006-04-15
CN1659163A (zh)	2005-08-24
ECSP045471A (es)	2005-01-28
CA2488242A1 (en)	2003-12-11
AR040239A1 (es)	2005-03-23
NO329351B1 (no)	2010-10-04
PL372589A1 (en)	2005-07-25
ES2258722T3 (es)	2006-09-01
KR20050005532A (ko)	2005-01-13
CN1324024C (zh)	2007-07-04

Publication	Publication Date	Title
BRPI0409109A (pt)	2006-03-28	novos compostos
MEP45308A (en)	2011-02-10	[1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
DE602004017174D1 (de)	2008-11-27	Phenoxyessigsäure-derivate zur behandlung von störungen der atemwege
BR0307291A (pt)	2004-12-07	Composto; processo para a preparação de um composto; composição farmacêutica; uso de um composto; método para o tratamento e profilaxia de distúrbios diversos e de obesidade em um humano
DE60220887D1 (de)	2007-08-09	Agonisten von beta-adrenorezeptoren
ATE381535T1 (de)	2008-01-15	Phenethanolaminderivate
DE602004030222D1 (de)	2011-01-05	2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen
BRPI0408251A (pt)	2006-03-01	compostos de pirazina como inibidores do fator de crescimento transformante (tgf)
SE0102764D0 (sv)	2001-08-17	Compounds
MY151336A (en)	2014-05-15	Glucopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture.
BR0314302A (pt)	2005-07-05	Compostos de pirazol como inibidores do fator de crescimento trnasformante (tgf)
YU35503A (sh)	2006-05-25	Nove kompozicije lekova bazirane na solima tiotropijuma i solima salmeterola
MY129422A (en)	2007-03-30	Medicinal compounds
MEP27608A (en)	2010-06-10	Substituted thiophenes, method for the production thereof, their use as a medicament or diagnostic reagent, and a medicament containing the same
NO20071577L (no)	2007-05-02	Bifenyloksyiddiksyrederivater for behandling av luftveissykdommer
BRPI0407055A (pt)	2006-01-17	Derivados de isotiazol
BRPI0510664B8 (pt)	2021-05-25	derivados de fenol e tiofenol 3 ou 4-monosubstituído, composição farmacêutica, combinação e uso dos compostos para tratamento de doenças relacionadas ao h3, incluindo transtornos do sistema nervoso central e transtornos inflamatórios
DE60024857D1 (de)	2006-01-19	Neue verbindungen
FR2869611A1 (fr)	2005-11-04	Derives de l'acide hexenoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
BRPI0816571A2 (pt)	2015-12-22	"composto, processo para preparação do composto, composição farmacêutica, agente e método para o tratamento de uma doença ou uma desordem do sistema nervoso central relacionada à ou afetada pelo recptor 5-ht6"
NO20030155D0 (no)	2003-01-13	Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
SE0101978D0 (sv)	2001-06-01	New compounds
BRPI0414191A (pt)	2006-10-31	tienoimidazóis substituìdos, processo para sua preparação, seu uso como medicamento ou diagnóstico bem como medicamento contendo os mesmos
BR112023027454A2 (pt)	2024-03-12	Composto, uso de um composto, medicamento, e, invenção de produto, processo, sistema, kit ou uso
BRPI0407212A (pt)	2006-01-24	2-aminoimidazóis substituìdos, processos para a sua preparação, sua aplicação como medicamento ou diagnóstico bem como o medicamento contendo os mesmos